What's New in Graves' Orbitopathy?

Update Item Information
Identifier 20180305_nanos_hottopic1_01-1
Title What's New in Graves' Orbitopathy?
Creator Jim Garrity, MD
Affiliation Mayo Clinic, Rochester, MN
Subject Graves' Orbitopathy; Thyroid Eye Disease; Biologic Medications; TSH-receptor; IGF-1 Receptor
Description Graves' orbitopathy (GO) is the most frequent extrathyroidal manifestation of Graves' disease (GD). Depending upon the diagnostic criteria used up to 50% of patients with GD have ophthalmic findings; with lid retraction/lid lag being the most common1-3. More severe, sight-threatening disease is seen in approximately 5% of hyperthyroid individuals4. While most GO requires no eye specific treatment,; approximately 15% of GO progress and is of interest to this presentation.
Date 2018-04
Language eng
Format video/mp4
Type Image/MovingImage
Source 2018 North American Neuro-Ophthalmology Society Annual Meeting
Relation is Part of NANOS Annual Meeting 2018: Hot Topics:What's New in the Orbit?
Collection Neuro-Ophthalmology Virtual Education Library: NANOS Annual Meeting Collection: https://novel.utah.edu/collection/nanos-annual-meeting-collection/
Publisher North American Neuro-Ophthalmology Society
Holding Institution Spencer S. Eccles Health Sciences Library, University of Utah
Rights Management Copyright 2017. For further information regarding the rights to this collection, please visit: https://NOVEL.utah.edu/about/copyright
ARK ark:/87278/s6ng8t3j
Context URL The NANOS Annual Meeting Neuro-Ophthalmology Collection: https://novel.utah.edu/collection/NAM/toc/
Setname ehsl_novel_nam
ID 1315748
Reference URL https://collections.lib.utah.edu/ark:/87278/s6ng8t3j
Back to Search Results